Description
The 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR will be held on February 21st-25th, 2024 in San Antonio, TX. Login to view Sessions and Papers saved as favorites. View schedules, locations, floor plans, and people. Attendees will now be able to facilitate their experience at the meeting using the mobile app.
Hide
Show More...
Screenshots
TANDEM 2024 FAQ
-
Is TANDEM 2024 free?
Yes, TANDEM 2024 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is TANDEM 2024 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does TANDEM 2024 cost?
TANDEM 2024 is free.
-
What is TANDEM 2024 revenue?
To get estimated revenue of TANDEM 2024 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Uzbekistan yet.
Ratings History
TANDEM 2024 Reviews
No Reviews in Uzbekistan
App doesn't have any reviews in Uzbekistan yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
TANDEM 2024 Installs
Last 30 days
TANDEM 2024 Revenue
Last 30 daysTANDEM 2024 Revenue and Downloads
Gain valuable insights into TANDEM 2024 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Business
- Publisher
- Convex Technologies
- Languages
- English, Dutch, French, German, Italian, Portuguese
- Recent release
- 1.0 (1 year ago )
- Released on
- Feb 6, 2024 (1 year ago )
- Also available in
- New Zealand, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Netherlands, Italy, Peru, Philippines, Pakistan, Saudi Arabia, Singapore, Ukraine, Uzbekistan, Vietnam, Dominican Republic, Argentina, Australia, Belarus, Canada, Switzerland, China, Colombia, Germany, United Arab Emirates, Ecuador, Egypt, Finland, France, United Kingdom, Indonesia, Ireland
- Last Updated
- 2 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.